HopeStage
Back to all studies
TerminatedNCT01403441

Radiosurgical Neuromodulation for Refractory Depression

Device studyAges 22–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 65 years.

Listed locations
StanfordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJuly 2010
Recruitment status
Terminated
Enrollment listed in the registry
3
Sponsor
Stanford University
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 22 Years to 65 Years
Official registry ID
NCT01403441
Official title
Show the full official title

Radiosurgical Neuromodulation for Refractory Depression

Recruitment & locations

Terminated

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Who can participate?

Listed age limits: 22 years to 65 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies